Junfeng Shi

1.0k total citations
54 papers, 645 citations indexed

About

Junfeng Shi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Junfeng Shi has authored 54 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Junfeng Shi's work include Cancer Cells and Metastasis (5 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (4 papers). Junfeng Shi is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (4 papers). Junfeng Shi collaborates with scholars based in China, United States and Germany. Junfeng Shi's co-authors include Xiao Han, Yujie Sun, Weiwei Tang, Yujie Sun, Sumeng Wang, Hanjin Wang, Hongyong Cao, Zhouxiao Li, Jin Xu and Jian Zhou and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Junfeng Shi

53 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junfeng Shi China 16 391 168 151 58 53 54 645
Guadalupe Domínguez-Gómez Mexico 16 373 1.0× 200 1.2× 135 0.9× 63 1.1× 48 0.9× 38 678
Aaron M. Sargeant United States 18 472 1.2× 130 0.8× 130 0.9× 84 1.4× 104 2.0× 30 819
Ji-Hyun Shin South Korea 12 402 1.0× 84 0.5× 115 0.8× 40 0.7× 71 1.3× 15 652
Gerson Moura Ferreira Brazil 11 350 0.9× 166 1.0× 181 1.2× 37 0.6× 110 2.1× 26 659
Nupur Mukherjee India 17 415 1.1× 154 0.9× 202 1.3× 52 0.9× 86 1.6× 33 689
Xin-Xin Long China 8 201 0.5× 80 0.5× 161 1.1× 50 0.9× 140 2.6× 14 537
Mingjun Dong China 12 280 0.7× 170 1.0× 79 0.5× 41 0.7× 61 1.2× 23 471
Nicolas Mouchet France 11 249 0.6× 55 0.3× 157 1.0× 38 0.7× 66 1.2× 16 518
Simone Marcone Ireland 16 443 1.1× 117 0.7× 98 0.6× 36 0.6× 82 1.5× 26 728
Shi Hu Jiang China 12 485 1.2× 107 0.6× 177 1.2× 31 0.5× 105 2.0× 14 695

Countries citing papers authored by Junfeng Shi

Since Specialization
Citations

This map shows the geographic impact of Junfeng Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Shi more than expected).

Fields of papers citing papers by Junfeng Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfeng Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Shi. The network helps show where Junfeng Shi may publish in the future.

Co-authorship network of co-authors of Junfeng Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Junfeng Shi. A scholar is included among the top collaborators of Junfeng Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfeng Shi. Junfeng Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Junfeng, Yifeng Cheng, Lixue Wang, et al.. (2025). SR-B1 deficiency suppresses progression in acute myeloid leukemia via ferroptosis and reverses resistance to venetoclax. Free Radical Biology and Medicine. 233. 24–38. 3 indexed citations
2.
Bian, Jin‐Song, Weiwei Chen, Junfeng Shi, et al.. (2025). Androgen receptor–induced lncRNA SOX2-OT promotes triple-negative breast cancer tumorigenesis via targeting miR-320a-5p–CCR5 axis. Journal of Biological Chemistry. 301(4). 108428–108428. 1 indexed citations
3.
Zhu, Yinxing, Junfeng Shi, Xiaowei Wei, et al.. (2024). Plasma Thioredoxin Reductase as a Potential Diagnostic Biomarker for Breast Cancer. Clinical Breast Cancer. 24(6). e464–e473.e3. 1 indexed citations
4.
Zhu, Yinxing, Junfeng Shi, Xiaowei Wei, et al.. (2023). Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer. Technology in Cancer Research & Treatment. 22. 2223926883–2223926883. 1 indexed citations
5.
Liang, Xiaowen, Nan Chen, Yun Chen, et al.. (2023). Low‑dose anlotinib combined with EGFR‑TKI can be used as an alternative for EGFR‑TKI‑resistant non‑small cell lung cancer in elderly patients. Oncology Letters. 26(2). 323–323. 3 indexed citations
6.
Wei, Ying, Junfeng Shi, Kai Cheng, et al.. (2023). Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies. Molecular Therapy — Oncolytics. 28. 293–306. 13 indexed citations
7.
Li, Xiao, Liangliang Wu, Zhiying Zheng, et al.. (2022). Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of Immunotherapy. Journal of Oncology. 2022. 1–12. 4 indexed citations
8.
Li, Jianming, Junfeng Shi, Qi Wang, et al.. (2022). Prevalence of Leptospira in murine in China: A systematic review and meta-analysis. Frontiers in Veterinary Science. 9. 944282–944282. 5 indexed citations
9.
Wang, Qi, Tian Tian, Ziyang Chen, et al.. (2022). A Meta-Analysis of Bovine Chlamydia Prevalence in Cattle in China from 1989 to 2020. Vector-Borne and Zoonotic Diseases. 22(2). 76–92. 1 indexed citations
10.
Gong, Qing‐Long, Qi Wang, Rui Zhang, et al.. (2022). Prevalence of Toxoplasma gondii infection in chickens in China during 1993–2021: a systematic review and meta-analysis. Parasitology Research. 121(1). 287–301. 5 indexed citations
11.
Wang, Jianzhong, et al.. (2021). MiRNA-26a inhibits myocardial infarction-induced apoptosis by targeting PTEN via JAK/STAT pathways. PubMed. 165. 203661–203661. 13 indexed citations
12.
Shi, Junfeng, Qing‐Long Gong, Bo Zhao, et al.. (2021). Seroprevalence of Brucellosis in Buffalo Worldwide and Associated Risk Factors: A Systematic Review and Meta-Analysis. Frontiers in Veterinary Science. 8. 649252–649252. 15 indexed citations
13.
Xu, Jin, Junfeng Shi, Weiwei Tang, et al.. (2020). ROR2 promotes the epithelial‐mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer. Journal of Cellular Biochemistry. 121(10). 4142–4153. 26 indexed citations
14.
Hensley, Patrick J., Jieming Li, Yang Zhang, et al.. (2020). Integrin-associated CD151 is a suppressor of prostate cancer progression.. PubMed Central. 12(4). 1428–1442. 10 indexed citations
15.
Zhang, Yang, Kai Cheng, Bingwei Xu, et al.. (2020). Epigenetic Input Dictates the Threshold of Targeting of the Integrin-Dependent Pathway in Non-small Cell Lung Cancer. Frontiers in Cell and Developmental Biology. 8. 652–652. 13 indexed citations
16.
Shi, Junfeng, Yi Chen, Yuetong Chen, et al.. (2018). Alloreactive cytotoxic T lymphocyte immunotherapy treatment of a patient with metastatic prostate cancer. Medicine. 97(24). e11111–e11111. 4 indexed citations
17.
Wei, Jingsun, Honghong Zhang, Xia Chu, et al.. (2018). Influence of TS (rs34743033) and RUNX1 (rs2014300) gene polymorphisms on survival outcomes of fluorouracil-based chemotherapy in Chinese advanced gastric cancer patients. Cancer Management and Research. Volume 10. 1429–1437. 5 indexed citations
18.
Shi, Junfeng, et al.. (2014). Expression of carcinoembryonic antigen-related cell adhesion molecule 1(CEACAM1) and its correlation with angiogenesis in gastric cancer. Pathology - Research and Practice. 210(8). 473–476. 22 indexed citations
19.
Tao, Weiwei, Junfeng Shi, Qian Zhang, et al.. (2013). Egr-1 enhances drug resistance of breast cancer by modulating MDR1 expression in a GGPPS-independent manner. Biomedicine & Pharmacotherapy. 67(3). 197–202. 28 indexed citations
20.
Shi, Junfeng, et al.. (2002). Therapeutic Efficacy of Astragalus in Patients with Chronic Glomerulonephritis. 22(3). 245–247. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guadalupe Domínguez-Gómez Breakdown of academic impact, for papers by Aaron M. Sargeant Breakdown of academic impact, for papers by Ji-Hyun Shin Breakdown of academic impact, for papers by Gerson Moura Ferreira Breakdown of academic impact, for papers by Nupur Mukherjee Breakdown of academic impact, for papers by Xin-Xin Long Breakdown of academic impact, for papers by Mingjun Dong Breakdown of academic impact, for papers by Nicolas Mouchet Breakdown of academic impact, for papers by Simone Marcone Breakdown of academic impact, for papers by Shi Hu Jiang
Rankless by CCL
2026